latest news releases from the newsroom
Harwood Feffer LLP
Wechsler Harwood Commences Class Action Suit Against BellSouth Corp. -- BLS
NEW YORK, Sept. 17, 2002 (PRIMEZONE) -- The law firm of Wechsler Harwood LLP ("Wechsler Harwood") announces that a class action has been commenced in the United States District Court for the Northern District of Georgia on behalf all persons who purchased or acquired BellSouth Corp. (NYSE:BLS) ("BellSouth" or the "Company") securities between the period of January 22, 2001 and July 19, 2002, inclusive (the Class Period) against defendants BellSouth and certain of its officers and directors.
Harwood Feffer LLP
Class Action Suit Against HPL Technologies, Inc. Commenced by Wechsler Harwood LLP -- HPLAE
NEW YORK, Sept. 17, 2002 (PRIMEZONE) -- The law firm of Wechsler Harwood LLP ("Wechsler Harwood") announces that a class action has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of HPL Technologies, Inc. ("HPL" or the "Company") (Nasdaq:HPLAE) securities between July 31, 2001 and July 18, 2002, inclusive (the "Class Period") against defendants HPL and certain of its officers.
Women First HealthCare, Inc.
Women First HealthCare Emphasizes Internal Growth Opportunities at Bear Stearns Healthcare Conference
SAN DIEGO, Calif., Sept. 17, 2002 (PRIMEZONE) -- Presenting at Bear Stearns 15th Annual Healthcare Conference in New York today, Women First HealthCare, Inc. (Nasdaq:WFHC) chairman, president and CEO Edward F. Calesa told attendees that the Company's priority is on managing and accelerating the growth of the Company's lead products -- Esclim(tm) (estradiol transdermal system), Vaniqa(r) (eflornithine hydrochloride) Cream, 13.9%, indicated for the reduction of unwanted facial hair in women, and Synalgos(r) DC painpak (drocode (dihydrocodeine) bitartrate, aspirin and caffeine). Calesa reminded attendees that product acquisitions continue to be an important element in the specialty pharmaceutical business model and will still play an important, albeit, secondary role in the Company's overall growth strategy.
Harsco Corporation Declares Regular Quarterly Cash Dividend
HARRISBURG, Pa., Sept. 17, 2002 (PRIMEZONE)-- The Board of Directors of Harsco Corporation (NYSE:HSC) today declared a regular quarterly cash dividend of 25 cents per share, or $1.00 per share on an annualized basis. The dividend is payable November 15, 2002 to stockholders of record as of October 15, 2002. The action marks the 210th consecutive cash dividend paid to Harsco stockholders at the same or increased rate. Harsco has paid dividends each year since 1939, including nine dividend increases in the last ten years.